Serotonin reuptake inhibitors in Obsessive-Compulsive Disorder: antidepressant or antiobsessional agents?
The recommended pharmacological agents for the treatment of Obsessive-Compulsive Disorder (OCD) are serotonin reuptake inhibitors (SRI), used also as antidepressant drugs. Nevertheless, the therapeutic profile of SRIs shows a lot of differences in OCD and in depression, as demonstrated in the trials...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd
2009-03-01
|
Series: | Clinical Management Issues |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/558 |